(Q43036651)

English

MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.

scientific article published on 10 June 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

S Kutscher

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

S Allgayer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

C J Dembek

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

J R Bogner

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

F D Goebel

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

V Erfle

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

10 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1372-1383

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20535218%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

https://scigraph.springernature.com/pub.10.1038/gt.2010.90

0 references

The latent HIV-1 reservoir in patients undergoing HAART: an archive of pre-HAART drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Therapeutic immunization for HIV.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Therapeutic immunization strategies for the control of HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

T-cell quality in memory and protection: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Human immunodeficiency virus type 1 controllers but not noncontrollers maintain CD4 T cells coexpressing three cytokines

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Signals required for programming effector and memory development by CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

CD4 memory T cells divide poorly in response to antigen because of their cytokine profile

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

IL-2 production correlates with effector cell differentiation in HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Direct access to CD4+ T cells specific for defined antigens according to CD154 expression.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vaccinia virus Ankara/HIV-1 Gag vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Functional signatures of protective antiviral T-cell immunity in human virus infections.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Proliferative capacity of epitope-specific CD8 T-cell responses is inversely related to viral load in chronic human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Role of CD40-dependent down-regulation of CD154 in impaired induction of CD154 in CD4(+) T cells from HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

DNA gag/adenovirus type 5 (Ad5) gag and Ad5 gag/Ad5 gag vaccines induce distinct T-cell response profiles

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Antigen persistence is required throughout the expansion phase of a CD4(+) T cell response

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Increased detection of proliferating, polyfunctional, HIV-1-specific T cells in DNA-modified vaccinia virus Ankara-vaccinated human volunteers by cultured IFN-gamma ELISPOT assay

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

The Future of Smallpox Vaccination: is MVA the key?

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

21 January 2018

Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

7 January 2021

based on heuristic

inferred from DOI database lookup

CD40-CD40 ligand

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

7 January 2021

based on heuristic

inferred from DOI database lookup

Registration of clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

7 January 2021

based on heuristic

inferred from DOI database lookup

Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

7 January 2021

based on heuristic

inferred from DOI database lookup

One step forward, two steps back--will there ever be an AIDS vaccine?

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

7 January 2021

based on heuristic

inferred from DOI database lookup

Lessons from IAVI-006, a phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.90

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43036651&oldid=1590001601"